STOCK TITAN

CareDx to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

CareDx (Nasdaq: CDNA), a precision medicine company specializing in transplant healthcare solutions, has announced its participation in three upcoming investor conferences. The company will present at the Jefferies London Healthcare Conference on November 19 at 4:00 AM EST, the Stephens Investment Conference in Nashville on November 21 at 9:00 AM EST, and the Piper Sandler Healthcare Conference in New York on December 4 at 10:10 AM EST. Interested parties can access the webcasts through CareDx's Investor Relations website at investors.caredx.com.

CareDx (Nasdaq: CDNA), un'azienda di medicina di precisione specializzata in soluzioni per la salute dei trapianti, ha annunciato la sua partecipazione a tre prossime conferenze per investitori. L'azienda presenterà alla Jefferies London Healthcare Conference il 19 novembre alle 4:00 AM EST, alla Stephens Investment Conference a Nashville il 21 novembre alle 9:00 AM EST, e alla Piper Sandler Healthcare Conference a New York il 4 dicembre alle 10:10 AM EST. Le parti interessate possono accedere alle trasmissioni in diretta tramite il sito web delle Relazioni con gli Investitori di CareDx su investors.caredx.com.

CareDx (Nasdaq: CDNA), una empresa de medicina de precisión especializada en soluciones de salud para trasplantes, ha anunciado su participación en tres próximas conferencias para inversores. La compañía presentará en la Jefferies London Healthcare Conference el 19 de noviembre a las 4:00 AM EST, en la Stephens Investment Conference en Nashville el 21 de noviembre a las 9:00 AM EST, y en la Piper Sandler Healthcare Conference en Nueva York el 4 de diciembre a las 10:10 AM EST. Las partes interesadas pueden acceder a las transmisiones web a través del sitio web de Relaciones con Inversores de CareDx en investors.caredx.com.

CareDx (Nasdaq: CDNA)는 이식 건강 관리 솔루션을 전문으로 하는 정밀 의학 회사로, 다가오는 세 가지 투자자 회의에 참여할 것이라고 발표했습니다. 이 회사는 11월 19일 오전 4시 EST에 Jefferies London Healthcare Conference에서 발표하고, 11월 21일 오전 9시에 내슈빌에서 열리는 Stephens Investment Conference에, 그리고 12월 4일 오전 10시 10분 EST에 뉴욕에서 열리는 Piper Sandler Healthcare Conference에 참석할 예정입니다. 관심 있는 분들은 CareDx의 투자자 관계 웹사이트인 investors.caredx.com을 통해 웹캐스트에 접속할 수 있습니다.

CareDx (Nasdaq: CDNA), une entreprise de médecine de précision spécialisée dans les solutions de santé liées aux greffes, a annoncé sa participation à trois prochaines conférences pour investisseurs. L'entreprise se présentera à la Jefferies London Healthcare Conference le 19 novembre à 4h00 EST, à la Stephens Investment Conference à Nashville le 21 novembre à 9h00 EST, et à la Piper Sandler Healthcare Conference à New York le 4 décembre à 10h10 EST. Les parties intéressées peuvent accéder aux diffusions en direct via le site Web des Relations Investisseurs de CareDx à investors.caredx.com.

CareDx (Nasdaq: CDNA), ein Unternehmen für Präzisionsmedizin, das sich auf Lösungen im Bereich Transplantationsmedizin spezialisiert hat, hat seine Teilnahme an drei bevorstehenden Investorenkonferenzen bekannt gegeben. Das Unternehmen wird am 19. November um 4:00 Uhr EST auf der Jefferies London Healthcare Conference präsentieren, am 21. November um 9:00 Uhr EST auf der Stephens Investment Conference in Nashville und am 4. Dezember um 10:10 Uhr EST auf der Piper Sandler Healthcare Conference in New York. Interessierte können die Webcasts über die Investor-Relations-Website von CareDx unter investors.caredx.com abrufen.

Positive
  • None.
Negative
  • None.

BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced the company will participate in the following investor conferences.

  • Jefferies London Healthcare Conference 2024 in London, UK. Presentation on Tuesday, November 19 at 9:00 AM GMT/4:00 AM EST
  • Stephens Investment Conference (NASH2024) in Nashville, TN. Fireside chat on Thursday, November 21 at 8:00 AM CST/9:00 AM EST
  • Piper Sandler Healthcare Conference in New York, NY. Presentation on Wednesday, December 4 at 10:10 AM EST

To listen to the webcast, please visit the Events & Presentations section of CareDx’s Investor Relations website at: investors.caredx.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

CareDx, Inc.

Media Relations

Anna Czene

818-731-2203

aczene@caredx.com



Investor Relations

Greg Chodaczek

investor@caredx.com

Source: CareDx, Inc.

FAQ

When is CareDx (CDNA) presenting at the Jefferies London Healthcare Conference 2024?

CareDx will present at the Jefferies London Healthcare Conference on Tuesday, November 19 at 9:00 AM GMT/4:00 AM EST.

Which investor conferences will CareDx (CDNA) attend in late 2024?

CareDx will attend three conferences: Jefferies London Healthcare Conference, Stephens Investment Conference in Nashville, and Piper Sandler Healthcare Conference in New York.

How can investors access CareDx's (CDNA) conference presentations?

Investors can access the webcasts through the Events & Presentations section of CareDx's Investor Relations website at investors.caredx.com.

What time is CareDx's (CDNA) presentation at the Piper Sandler Healthcare Conference?

CareDx will present at the Piper Sandler Healthcare Conference on Wednesday, December 4 at 10:10 AM EST.

CareDx, Inc.

NASDAQ:CDNA

CDNA Rankings

CDNA Latest News

CDNA Stock Data

1.11B
51.79M
3.45%
96.05%
5.73%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
BRISBANE